Dana-Farber Cancer Institite

Boston, Massachusetts 02215

2 studies enrolling now · 9 studies all time

What they study most

Breast Cancer, Breast Cancer Female, Breast Cancer Metastatic, HER2-positive Breast Cancer, Her 2 Positive Breast Cancer, Hormone Receptor Positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Invasive Carcinoma of the Breast, Low-grade Glioma, Malignant Childhood Central Nervous System Neoplasm, Metastatic Colorectal Cancer

Studies at this site

• VS-6766+Abema+Fulv in Met HR+/HER- BC — Recruiting now
• A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer — Running, not enrolling
• Olaparib With Ceralasertib in Recurrent Osteosarcoma — Running, not enrolling
• A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN) — Running, not enrolling
• DAY101 In Gliomas and Other Tumors — Completed
• B7-H3.CD28Z.CART in Solid Tumors — Starting soon
• GVAX Plus Checkpoint Blockade in Neuroblastoma — Stopped early
• Dabrafenib + Trametinib + PDR001 In Colorectal Cancer — Status unconfirmed
• A-protein Levels in Adult and Pediatric Brain Tumor Patients — Completed